Risk of Asthma Exacerbation, Asthma-Related Health Care Utilization and Costs, and Adherence to Controller Therapy in Patients with Asthma Receiving Fluticasone Propionate/Salmeterol Inhalation Powder 100 μg/50 μg Versus Mometasone Furoate Inhalation Powder

By Hagiwara May  

Journal of Asthma, Vol. 50, Iss. 3, 2013-04 ,pp. : 287-295

Informa Healthcare

Access to resources Recommend Favorite

Comparison of Mometasone Furoate Dry Powder Inhaler and Fluticasone Propionate Dry Powder Inhaler in Patients with Moderate to Severe Persistent Asthma Requiring High-Dose Inhaled Corticosteroid Therapy: Findings from a Noninferiority Trial

By Harnest Ulf   Price David   Howes Tim   Sussman Gordon  

Journal of Asthma, Vol. 45, Iss. 3, 2008-04 ,pp. : 215-220

Informa Healthcare

Access to resources Recommend Favorite

Fluticasone Propionate HFA-134a Pressurized Metered-Dose Inhaler in Adolescents and Adults with Moderate to Severe Asthma

By Pinnas Jacob   Noonan Michael   Weinstein Steven   Chervinsky Paul   Scott Catherine   Herje Nancy   Wu Wei   Crim Courtney  

Journal of Asthma, Vol. 42, Iss. 10, 2005-12 ,pp. : 865-871

Informa Healthcare

Access to resources Recommend Favorite

Salmeterol/Fluticasone Propionate versus Fluticasone Propionate Plus Montelukast: A Cost-Effective Comparison for Asthma

By Pieters Willem R.  

Treatments in Respiratory Medicine, Vol. 4, Iss. 2, 2005-01 ,pp. : 129-138

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of Fluticasone Propionate/Salmeterol HFA 134A MDI in Patients with Mild‐to‐Moderate Persistent Asthma

By Pearlman David   Peden David   Condemi John   Weinstein Steven   White Martha   Baitinger Leslie   Scott Catherine   Ho Shu   House Karen   Dorinsky Paul  

Journal of Asthma, Vol. 41, Iss. 8, 2004-01 ,pp. : 797-806

Informa Healthcare

Access to resources Recommend Favorite